

PRISMA
PRECISION MEDICINE IN AUTISM
Leveraging genomics for neurodevelopmental care
AVAILABLE NOW!
PRISMA LIBRARY OF LIFE
We are proud to share our educational video as part of our implementation science initiatives. Designed for individuals on the autism spectrum, families, clinicians, and the broader community, this engaging resource explains key concepts such as autism, genetics, and genetic testing in a clear and accessible way. Meet Bo, DiNA, and their friends as they explore how genetics helps us better understand autism and related neurodevelopmental conditions.
Why PRISMA
Prisms are wonderful objects; a simple but elegant piece of glass that can take a single stream of light and transform it into a beautiful spectrum of colors, which can be used to shine light in dark places so that we can better see the way.
That description recapitulates the mission and vision of our Precision Medicine in Autism (PRISMA) group; we aim to understand the unique strengths and challenges of people with autism or other neurodevelopmental conditions in the context of the diverse rare genetic changes that can be found in up to 1 in 3 people with these diagnoses. By bringing together research, clinical care, education, and community engagement, we focus on creating a comprehensive strategy to improve the healthcare of people with psychiatric conditions stemming from rare genomic disorders. The research group is led by Daniel Moreno De Luca, MD, MS, CASA Research Chair and Associate Professor at the University of Alberta, in collaboration with CASA Mental Health. Plus, it highlights our focus on diversity, as “prisma” is the Spanish word for prism!

NEWS
Our study, Attitudes, Perceptions & Results About Genetic Testing for Autism, is enrolling individuals with autism, their families, and physicians in Alberta. It explores experiences and views on genetic testing for autism. Participation includes an online survey and interview, taking about two hours. Click below for more details.
Our research study "A Genomic Approach to Precision Medicine for Autism and Neurodevelopmental Conditions" is enrolling children and adults who have had diagnostic genetic testing that showed a deletion or a duplication in chromosome 17q12 to understand how genetics can impact their healthcare. Click below for more details.



